In 2022, Dr. Paul Savage sold his age management practice, retired, and moved to Brazil. But retirement didn’t last long. A groundbreaking study on the potential of TPE to slow aging processes reignited Dr. Savage’s passion for innovation. The study, a double-blind, placebo-controlled trial exploring TPE’s role in health rejuvenation, was a revelation — the “Aha” moment that brought him out of retirement with a renewed sense of purpose.
Dr. Savage realized this was his calling. With decades of medical breakthroughs under his belt, including pioneering hormone therapy in the early 2000s and age management solutions, he saw an opportunity to take health optimization to a new level. Joined by visionary physicians like Dr. Pamela Smith, he dedicated the last several years to advancing the use of data, disease tracking, and detection in personalized medicine to create a revolutionary approach to detoxification.
This journey culminated in the creation of PlasmaXchange, a patent-pending protocol that uses TPE in ways never before possible to truly detoxify the body. While TPE has been utilized in clinical settings for nearly 50 years to address medical conditions, Dr. Savage and his team reimagined its potential. They developed new use cases for modern health, focusing on removing the environmental toxins that burden the body and prevent optimal wellness.
Dr. Savage calls PlasmaXchange the pinnacle of his career — a fusion of his experience in groundbreaking medical innovations and his vision for the future of health. MDLifespan now stands at the forefront of personalized medicine, offering transformative solutions to address one of the greatest health challenges of our time.